MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - Insider Trades

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MRNX stock inside the company?

Rallies tracks MRNX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MRNX News

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Common questions about MRNX

Who is trading MRNX stock inside the company?
Rallies tracks MRNX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for MRNX?
Yes. Rallies tracks MRNX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX